These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26330257)

  • 21. Opportunities and challenges in phenotypic drug discovery: an industry perspective.
    Moffat JG; Vincent F; Lee JA; Eder J; Prunotto M
    Nat Rev Drug Discov; 2017 Aug; 16(8):531-543. PubMed ID: 28685762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Driving drug discovery: the fundamental role of academic labs.
    Silber BM
    Sci Transl Med; 2010 May; 2(30):30cm16. PubMed ID: 20445199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mergers and innovation in the pharmaceutical industry.
    Comanor WS; Scherer FM
    J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of high-content screening (HCS) technology and its importance to drug discovery.
    Fraietta I; Gasparri F
    Expert Opin Drug Discov; 2016; 11(5):501-14. PubMed ID: 26971542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift.
    Sams-Dodd F
    Drug Discov Today; 2013 Mar; 18(5-6):211-7. PubMed ID: 23131208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The continuing evolution of the drug discovery process in the pharmaceutical industry.
    Ratti E; Trist D
    Farmaco; 2001; 56(1-2):13-9. PubMed ID: 11347954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.
    Kell DB
    FEBS J; 2013 Dec; 280(23):5957-80. PubMed ID: 23552054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery research: the scientific challenge of finding new antibiotics.
    Livermore DM;
    J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancing the drug discovery and development process.
    Nicolaou KC
    Angew Chem Int Ed Engl; 2014 Aug; 53(35):9128-40. PubMed ID: 25045053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengthening the Competitiveness of Japan's Pharmaceutical Industry: Analysis of Country Differences in the Origin of New Drugs and Japan's Highly Productive Firm.
    Okuyama R
    Biol Pharm Bull; 2023; 46(5):718-724. PubMed ID: 37121698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analysis of original research contributions toward FDA-approved drugs.
    Patridge EV; Gareiss PC; Kinch MS; Hoyer DW
    Drug Discov Today; 2015 Oct; 20(10):1182-7. PubMed ID: 26113307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho Chi lecture. Pharmaceutical sciences in the next millennium.
    Triggle DJ
    Ann Pharmacother; 1999 Feb; 33(2):241-6. PubMed ID: 10084422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current challenges for the pharmaceutical research industry].
    Chalchat B
    Ann Pharm Fr; 1993; 51(1):16-25. PubMed ID: 8215118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study.
    Parsons S; Starling B; Mullan-Jensen C; Tham SG; Warner K; Wever K
    BMJ Open; 2016 Jan; 6(1):e008928. PubMed ID: 26743701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network approaches to drug discovery.
    Chandra N; Padiadpu J
    Expert Opin Drug Discov; 2013 Jan; 8(1):7-20. PubMed ID: 23140510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragment-based approaches in drug discovery and chemical biology.
    Scott DE; Coyne AG; Hudson SA; Abell C
    Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications.
    Shih HP; Zhang X; Aronov AM
    Nat Rev Drug Discov; 2018 Jan; 17(1):19-33. PubMed ID: 29075002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomics and new technologies as catalysts for change in the drug discovery paradigm.
    Hanke J
    J Law Med Ethics; 2000; 28(4 Suppl):15-22. PubMed ID: 11244839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons from the Fersht laboratory could be vital for the future of the pharmaceutical industry.
    Ward WH
    Protein Eng Des Sel; 2011 Jan; 24(1-2):65-7. PubMed ID: 20876191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.